Related Experiment Video
Updated: Dec 6, 2025
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.1K
Resident Memory T Cells and Their Effect on Cancer
Daniel J Craig1, Justin F Creeden1, Katelyn R Einloth1
1Department of Chemical Engineering, University of Toledo Medical Center, Toledo, OH 43614, USA.
Vaccines
|October 6, 2020
Summary
Resident memory T (TRM) cells reside in tissues, aiding long-term immunity and cancer immunosurveillance. Understanding their mechanisms could improve cancer therapies and prognoses.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Resident memory T (TRM) cells are tissue-resident CD8+ T cells crucial for sustained immunity.
- They are vital for viral infection response and local cancer immunosurveillance.
- TRM cells are characterized by CD69/CD103 co-expression and distinct transcription factor profiles (Runx3, Blimp1, Hobit).
Purpose of the Study:
- To review the mechanisms governing TRM cell differentiation and maintenance.
- To explore the role of TRM cells in tumor immunity and their association with patient survival.
- To discuss potential therapeutic applications of TRM cells in cancer treatment and prognosis.
Main Methods:
- Review of existing literature on TRM cell biology, immunology, and cancer research.
- Analysis of TRM cell phenotype, function, and transcriptional regulation.
- Examination of the clinical relevance of TRM cells in cancer patients and immunotherapy response.
Main Results:
- TRM cells exhibit enhanced adhesion molecule expression for tissue retention and reduced proliferation.
- Their accumulation in tumors correlates with improved survival and better response to immunotherapies like anti-PD-1 and anti-CTLA-4.
- TRM cells produce both regulatory and immune-responsive cytokines, influencing the local tumor microenvironment.
Conclusions:
- TRM cells are key players in local tissue immunity and cancer immunosurveillance.
- Further research into TRM cell mechanisms can unlock novel therapeutic strategies.
- TRM cell presence may serve as a prognostic biomarker in cancer patients undergoing immunotherapy.
Related Concept Videos
01:23Cells of the Adaptive Immune Response
8.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.1K
01:23Immunological Memory
14.5K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
14.5K
01:27Tumor Immunotherapy
1.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.3K
01:22T Cell Activation and Clonal Selection
14.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.2K
01:40Cell-mediated Immune Responses
82.1K
Overview
82.1K
01:27Cytotoxic T Cells-mediated Immune Response
6.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K